收稿日期: 2020-08-11
网络出版日期: 2021-03-25
基金资助
河北省卫生厅课题(20190408)
The finger-ring test in sarcopenia screening for older adults
目的 评价指环测试在社区老年人肌少症筛查中的应用价值。方法 对符合标准的303名社区老年人,应用指环测试进行肌少症评估,以亚洲肌少症工作组提出的肌少症诊断标准为依据,使用灵敏度、特异度、约登指数、似然比、预测值、Kappa系数等指标评估指环测试的准确性。结果 根据亚洲肌少症工作组提出的诊断标准,肌少症老年人80名,非肌少症老年人223名。指环测试灵敏度为70.00%,特异度为85.65%,约登指数为0.56,阳性、阴性似然比分别为4.88、0.35,阳性、阴性预测值分别为63.64%、88.84%,Kappa系数为0.46。 结论 指环测试作为一种自我筛查工具,在社区老年人中具有较好的筛检价值。
温鹏天 , 张瑞丽 , 李慧娟 , 王冰飞 . 指环测试在社区老年人肌少症筛查中的应用[J]. 中华护理教育, 2021 , 18(3) : 275 -278 . DOI: 10.3761/j.issn.1672-9234.2021.03.017
Objective To assess the application value of a screening tool—finger-ring test in sarcopenia screening for older adults in the community. Methods The finger-ring test was used to evaluate the sarcopenia for 303 community older adults who met the criteria. The Asian Working Group for Sarcopenia（AWGS） was used for golden criteria. The indicators including sensitivity,specificity,Youden index,likelihood ratio,predictive value,and Kappa coefficient were applied to evaluate the diagnostic appropriateness of the finger-ring test. Results According to the AWGS diagnostic criteria,there were 80 older adults with sarcopenia and 223 older adults without sarcopenia. The finger-ring test had a sensitivity of 70.00%,specificity of 85.65%,Youden index of 0.56,positive and negative likelihood ratios of 4.88 and 0.35,positive and negative predictive values of 63.64% and 88.84%,and Kappa coefficient of 0.46. Conclusion The finger-ring test,as a self-screening tool,has good screening value and can be used to screen for sarcopenia for the older adults in the community.
Key words： Community Health Nursing; Aged; Sarcopenia; Finger-ring test
| [1] | Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019,393(10191):2636-2646. |
| [2] | Terracciano C, Celi M, Lecce D, et al. Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis[J]. Osteoporos Int, 2013,24(3):1095-1100. |
| [3] | Pinedo-Villanueva R, Westbury LD, Syddall HE, et al. Health care costs associated with muscle weakness:a UK population-based estimate[J]. Calcif Tissue Int, 2019,104(2):137-144. |
| [4] | 李敏, 宋瑰琦, 任海燕, 等. Ishii评分在社区老年人肌少症筛查中的应用[J]. 中国护理管理, 2018,18(8):1034-1038. |
| [4] | Li M, Song GQ, Ren HY, et al. The application of Ishii’s scores in the screening for sarcopenia in community elderly[J]. Chin Nurs Manag, 2018,18(8):1034-1038. |
| [5] | Li R, Hu X, Tan L, et al. Screening for sarcopenia with a self-reported cartoon questionnaire:combining SARC-F with finger-ring test[J]. J Nutr Heal Aging, 2020,24(10):1100-1106. |
| [6] | Tanaka T, Takahashi K, Akishita M, et al. “Yubi-wakka”(finger-ring)test:a practical self-screening method for sarcopenia,and a predictor of disability and mortality among Japanese community-dwelling older adults[J]. Geriatr Gerontol Int, 2018,18(2):224-232. |
| [7] | Fujii H, Kodani E, Kaneko T, et al. “yubi-wakka”(finger-ring)test:a tool to detect prefrailty in elderly populations,a pilot study[J]. J Clin Med Res, 2019,11(9):623-628. |
| [8] | Hiraoka A, Izumoto H, Ueki H, et al. Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle(yubi-wakka)test[J]. J Cachexia Sarcopenia Muscle, 2019,10(2):347-354. |
| [9] | Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020,21(3):300-307. |
| [10] | 黄悦勤. 临床流行病学[M]. 北京: 人民卫生出版社, 2002: 88-97. |
| [10] | Huang YQ. Clinical epidemiology[M]. Beijing: People’s Medical Publishing House, 2002: 88-97. |
| [11] | 宋世明, 杜红珍, 李增宁. 恶性肿瘤患者低相位角与营养风险和住院时间相关性研究[C]//第十届全国中西医结合营养学术会议论文集. 成都, 2019: 461-471. |
| [12] | 劳期迎, 曹殿青. 生物电阻抗测量技术临床应用与研究进展[J]. 中国处方药, 2019,17(2):29-31. |
| [12] | Lao QY, Cao DQ. Clinical application and research progress of bioelectrical impedance measurement technology[J]. J China Prescr Drug, 2019,17(2):29-31. |
| [13] | 闫岩, 华琳, 张建. 对诊断一致性Kappa系数及评价指标的探讨[J]. 中国卫生统计, 2007,24(3):313-315. |
| [13] | Yan Y, Hua L, Zhang J. Discussion on Kappa coefficient and evaluation index of diagnostic consistency[J]. Chin J Heal Stat, 2007,24(3):313-315. |
| [14] | Yang M, Lu J, Jiang J, et al. Comparison of four sarcopenia screening tools in nursing home residents[J]. Aging Clin Exp Res, 2019,31(10):1481-1489. |
| [15] | Ishida Y, Maeda K, Nonogaki T, et al. SARC-F as a screening tool for sarcopenia and possible sarcopenia proposed by AWGS 2019 in hospitalized older adults[J]. J Nutr Heal Aging, 2020(1):1-8. |
| [16] | Uemura K, Makizako H, Lee S, et al. The impact of sarcopenia on incident homebound status among community-dwelling older adults:a prospective cohort study[J]. Maturitas, 2018,113:26-31. |
| [17] | Akishita M, Kozaki K, Iijima K, et al. Chapter 1 Definitions and diagnosis of sarcopenia[J]. Geriatr Gerontol Int, 2018,18(Suppl 1):7-12. |
| [18] | Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:report of the European working group on sarcopenia in older people[J]. Age Ageing, 2010,39(4):412-423. |
/
| 〈 |
|
〉 |